Form 4: Life360 Director Sells Shares Under 10b5-1 Plan

Life360 Director Charles J. Prober exercised stock options and sold 7,930 shares of common stock on December 15, 2025, under a pre-established 10b5-1 trading plan.

Summary

• Director Charles J. Prober engaged in transactions involving Life360, Inc. common stock on December 15, 2025.
• Exercised stock options to acquire 7,930 shares of common stock at an exercise price of $11.18 per share.
• Simultaneously sold 7,930 shares of common stock at a price of $68.30 per share.
• The transactions were executed under a Rule 10b5-1 trading plan adopted on March 14, 2025.
• Following these transactions, beneficial ownership of common stock is 105,456 shares, which includes 1,357 restricted stock units.
• Remaining stock options beneficially owned are 87,230.
• Vesting terms for the stock option were corrected in this filing, having been inadvertently misreported in previous filings.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction under a 10b5-1 plan, indicating pre-planned activity rather than a reaction to new information. The correction of vesting terms is a minor administrative detail.

Positives

• The transactions were conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled sale not based on recent material nonpublic information.

Negatives

• A director selling shares, even under a pre-planned arrangement, could be perceived negatively by some investors.

Future Outlook

No specific future outlook or guidance is provided in this insider transaction report.

Management Comments

• The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.
• The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria.
• The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
• The vesting terms for the stock option reported herein were inadvertently misreported on the Reporting Person's initial Form 3 filed on June 27, 2022, Form 3/A filed on June 29, 2022, and subsequent Forms 4 reporting transactions in the stock option, and have been corrected as of this Form 4.

Industry Context

This is a routine insider transaction report, common for executives and directors managing their equity compensation and personal liquidity. It does not directly reflect broader industry trends or competitive dynamics.

Corporate Governance

Stakeholder Impact

• Shareholders: May view the sale as a director taking profits, but the 10b5-1 plan mitigates concerns about opportunistic selling. The correction of vesting terms improves transparency regarding executive compensation.

Next Steps

• The remaining 87,230 stock options will continue to vest in equal monthly installments until 100% vested, subject to the Reporting Person's continuing service.

Key Dates

Recommendation

This Form 4 reports a routine, pre-scheduled insider transaction under a 10b5-1 plan. It does not provide new fundamental information about the company's performance or strategic direction that would warrant a change in investment recommendation. The correction of vesting terms is an administrative detail. Investors should continue to hold based on broader company fundamentals rather than this specific insider transaction.

Keywords

Life360, LIF, Form 4, Insider Trading, Stock Option Exercise, Share Sale, Director Transaction, 10b5-1 Plan, Charles J. Prober